Brian T. Powl, Chief Commercial Officer at Kura Oncology, Inc. (KURA), sold 1,583 shares at $7.87 ($12K) on 2025-01-28, disclosed to the SEC on 2025-01-28.
Open-market sale of $12k KURA by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KURA | SELL | 2026-05-20 | $3K | — | Filing → |
| KURA | SELL | 2026-01-27 | $54K | — | Filing → |
| KURA | SELL | 2025-11-14 | $199K | — | Filing → |